InvestorsHub Logo
Followers 101
Posts 3125
Boards Moderated 0
Alias Born 09/21/2013

Re: None

Tuesday, 04/26/2022 11:13:42 AM

Tuesday, April 26, 2022 11:13:42 AM

Post# of 69
Just...pulled this...ziggy.


Protagonist Therapeutics: Biotechnology company Protagonist Therapeutics (NASDAQ:PTGX) remains on the Fintel short squeeze leaderboard at the same position it held last week. Fintel shows 12.8% of the float short and a borrow fee rate of 16.88. Short interest is climbing in the company’s shares, according to the report.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PTGX News